Assembly biosciences reports fourth quarter and year end 2023 financial results and recent highlights

South san francisco, calif., march 28, 2024 (globe newswire) -- assembly biosciences, inc. (nasdaq: asmb), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today reported financial results and recent highlights for the fourth quarter and year ended december 31, 2023.
ASMB Ratings Summary
ASMB Quant Ranking